These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 1889892)
21. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis]. Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107 [TBL] [Abstract][Full Text] [Related]
22. Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients. Lazarus JM; Hakim RM; Newell J Am J Kidney Dis; 1990 Aug; 16(2):101-8. PubMed ID: 2382644 [TBL] [Abstract][Full Text] [Related]
23. [Improvement of the anemia associated with multiple myeloma and renal dysfunction by recombinant human erythropoietin]. Nakata H; Matsuzaki M; Shimamoto Y; Yamaguchi M Rinsho Ketsueki; 1990 Oct; 31(10):1752-3. PubMed ID: 2255069 [TBL] [Abstract][Full Text] [Related]
24. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801 [TBL] [Abstract][Full Text] [Related]
25. Cardiac hemolysis and anemia refractory to erythropoietin: on anemia in dialysis patients. Evers J Nephron; 1995; 71(1):108. PubMed ID: 8538832 [No Abstract] [Full Text] [Related]
26. [Treatment of iron overload with combination of recombinant human erythropoietin and phlebotomy]. Nagafuji K; Shibuya T; Yanagida K; Okamura T; Nakamura M; Harada M; Niho Y; Yamano Y Rinsho Ketsueki; 1991 Jul; 32(7):791-5. PubMed ID: 1920844 [TBL] [Abstract][Full Text] [Related]
27. [Treatment of anemia in patients with chronic kidney insufficiency in hemodialysis with erythropoietin]. Prata MM; de Sousa FT; Barbas JV; da Costa AM; Vinhas J; Moreira P; Abrantes C; Lopes MC Acta Med Port; 1990; 3(3):149-53. PubMed ID: 2220424 [TBL] [Abstract][Full Text] [Related]
28. [An echocardiographic study of the left ventricular functional indices in pediatric patients on hemodialysis and in treatment with recombinant human erythropoietin (r-HuEPO)]. Seracini D; Pollini I; Lavoratti GC; Pela I; Materassi M; Danti D; De Simone L; Favilli S; Manetti A Pediatr Med Chir; 1994; 16(4):389-92. PubMed ID: 7816703 [TBL] [Abstract][Full Text] [Related]
29. Changes of enzyme activity levels in red blood cells in hemodialysis patients by recombinant human erythropoietin. Suzuki Y; Ogura Y; Otsubo O; Mimura N; Takaku F; Maeda T Nihon Jinzo Gakkai Shi; 1992 Sep; 34(9):1019-23. PubMed ID: 1479730 [TBL] [Abstract][Full Text] [Related]
30. [Successful treatment using iron depletion phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by secondary hemochromatosis]. Shinjo K; Takeshita A; Naito K; Ohnishi K; Hirabayashi N; Ohno R Rinsho Ketsueki; 2001 Jul; 42(7):571-4. PubMed ID: 11524849 [TBL] [Abstract][Full Text] [Related]
31. The impact of recombinant human erythropoietin on medical care costs for hemodialysis patients in Canada. Sheingold S; Churchill D; Muirhead N; Laupacis A; Labelle R; Goeree R Soc Sci Med; 1992 May; 34(9):983-91. PubMed ID: 1631611 [TBL] [Abstract][Full Text] [Related]
32. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]
33. [Initial response to treatment with erythropoietin in anemia caused by chronic renal insufficiency]. Sánchez Casajús A; Barrau J; Gómez Alamillo C; Jaurrieta F Sangre (Barc); 1990 Feb; 35(1):82-4. PubMed ID: 2333585 [TBL] [Abstract][Full Text] [Related]
34. Normalization of serum prolactin levels in hemodialysis patients on recombinant human erythropoietin. Schaefer RM; Kokot F; Kuerner B; Zech M; Heidland A Int J Artif Organs; 1989 Jul; 12(7):445-9. PubMed ID: 2767790 [TBL] [Abstract][Full Text] [Related]
35. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products. McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312 [TBL] [Abstract][Full Text] [Related]
36. [Multicenter study of darbepoetin alfa in the treatment of anemia secondary to chronic renal insufficiency on dialysis]. Martínez Castelao A; Reyes A; Valdés F; Otero A; López de Novales E; Pallardó L; Tabernero JM; Hernández Jaras J; Lladós F Nefrologia; 2003; 23(2):114-24. PubMed ID: 12778875 [TBL] [Abstract][Full Text] [Related]
37. Erythropoietin--advent of a new treatment. Winearls C Practitioner; 1987 Oct; 231(1436):1269-73. PubMed ID: 3333088 [No Abstract] [Full Text] [Related]
38. Red cell membrane during erythropoietin therapy in hemodialysis and in hemodiafiltration. Icardi A; Paoletti E; Traverso GB; Sarchi C; Cappelli G; Molinelli G Int J Artif Organs; 1991 Mar; 14(3):147-9. PubMed ID: 2045188 [TBL] [Abstract][Full Text] [Related]
39. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS). Marques da Costa R Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287 [TBL] [Abstract][Full Text] [Related]
40. [Utility of recombinant human erythropoietin on the anemia of elderly hemodialysis patients]. Ueyama H; Nakahashi H; Sawanishi K; Kuze M; Ono T Hinyokika Kiyo; 1992 Dec; 38(12):1429-35. PubMed ID: 1288237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]